Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion type Assertion NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_head.
- NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion description "[Overall, heterozygous TPMT genotypes did not predict adverse drug reactions but were significantly associated with a subgroup of patients experiencing nausea and vomiting as the predominant adverse reaction to AZA therapy (OR 5.5, 95% CI 1.4-21.3, P = 0.0206).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_provenance.
- NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion evidence source_evidence_literature NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_provenance.
- NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion SIO_000772 15167706 NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_provenance.
- NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion wasDerivedFrom befree-20140225 NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_provenance.
- NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_assertion wasGeneratedBy ECO_0000203 NP425406.RA5CNuTO0xGoubTp9NT1yaL9widVS80ah2runmo1T2EHo130_provenance.